The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results